KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TherapeuticsMD (TXMD) EPS (Basic): 2010-2024

Historic EPS (Basic) for TherapeuticsMD (TXMD) over the last 15 years, with Dec 2024 value amounting to -$0.20.

  • TherapeuticsMD's EPS (Basic) rose 120.00% to $0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.01, marking a year-over-year increase of 103.57%. This contributed to the annual value of -$0.20 for FY2024, which is 79.80% up from last year.
  • As of FY2024, TherapeuticsMD's EPS (Basic) stood at -$0.20, which was up 79.80% from -$0.99 recorded in FY2023.
  • Over the past 5 years, TherapeuticsMD's EPS (Basic) peaked at $12.41 during FY2022, and registered a low of -$21.66 during FY2021.
  • Over the past 3 years, TherapeuticsMD's median EPS (Basic) value was -$0.20 (recorded in 2024), while the average stood at $3.74.
  • Per our database at Business Quant, TherapeuticsMD's EPS (Basic) plummeted by 3,132.84% in 2021 and then spiked by 157.29% in 2022.
  • TherapeuticsMD's EPS (Basic) (Yearly) stood at -$0.67 in 2020, then plummeted by 3,132.84% to -$21.66 in 2021, then spiked by 157.29% to $12.41 in 2022, then plummeted by 107.98% to -$0.99 in 2023, then soared by 79.80% to -$0.20 in 2024.